When Congress first
introduced a hospice benefit into the Medicare program in 1982, it did so out
of the recognition that patients who are very near the end of life need special
treatment. Conventional medical care doesn’t work well for them; another type
of care, focused intensively on symptom management and delivered principally in
the home, tends to be far more beneficial. The problem—aside from the
psychological issue of both patients' and doctors’ reluctance to acknowledge the
imminence of the end of life—was how to pay for this kind of labor-intensive
care. The legislation, introduced on a trial basis at first and then on a permanent
basis in 1986, instituted an approach to payment that offered patients a trade:
either Medicare paid for what was assumed to be life-prolonging care (for
example, hospitalization and chemotherapy) or Medicare paid for what was
assumed to be exclusively comfort-oriented care (for example, home nursing and
medications such as morphine). The nice clean boundaries between
life-prolongation and comfort-maximization turned out to be rather fuzzy:
sometimes palliative care prolongs life more than does aggressive, high-tech
medicine and sometimes the treatments
that are thought of as life-prolonging, such as radiation therapy, are the best
way to maximize comfort. But leaving aside the issue of whether we should
decide what counts as life-prolonging on a case-by-case basis rather than by
category (ie viewing all chemotherapy as life-prolonging), the fundamental
principle remains—health insurance benefit packages necessarily involve both
inclusions and exclusions.
The trouble with the
structure of Medicare is that it provides well for the extremes, for people who
are very vigorous or who are imminently dying, but it doesn’t provide well for
those who are in between. To be fair, Medicare has evolved over the past ten
years and pays far more attention than previously to people with chronic
diseases and increasingly greater attention to people with multiple chronic diseases. It has
introduced disease management programs, typically involving nurses who help
patients adjust their own medications for diseases such as diabetes or heart
failure. But patients who are frail or who have moderate to severe dementia
benefit from many of the same intensive home care services as dying patients.
They also often want to avail themselves of many of the same kinds of high-tech
care as robust older patients. Medicare rightly balks at the prospect of paying
for everything—it’s just too expensive. So what people with frailty and
advancing dementia need is their own special Medicare benefit that is midway
between conventional Medicare and the hospice benefit. They need what I call
intermediate care; the way to pay for intermediate care is through a new
benefit tier.
The comprehensive
package—sandwiched between the intensive package and the palliative
package—would be modeled on the Program of All-Inclusive Care for Elders (PACE), a
very successful program in which only a very small number of patients have
enrolled, providing integrated, multidisciplinary care outside the hospital or
nursing home. Unlike PACE, it would not focus on the adult day health center
(many older people don’t want to go to “daycare,” where lots of the PACE
services are delivered) and it would not require that patients change
physicians (an impediment to joining PACE as currently conceived). In exchange
for the enhanced home services, the intermediate care benefit package would
exclude a variety of high tech, high expense medical care that is seldom useful
for frail or very demented patients. It would not cover ICU care. It would not
cover surgery for devices such as the Left Ventricular Assist Device, a kind of
partial artificial heart. It would exclude dialysis, which doesn’t prolong life
in frail elders. What the intermediate care benefit would provide is a
coordinated, integrated approach to care, with plans in place for what to do in
the most likely scenarios for a given patient—what to do when the patient with
advanced heart failure develops pulmonary edema, when the patient with advanced
emphysema develops pneumonia, or when the patient with moderately severe
dementia develops a fever. These plans would involve intensive home treatment
or transfer to a skilled nursing facility, but not the current approach of
emergency room—hospital—rehab—home. It would look similar to another variant of
Medicare than has been proposed, called MediCaring.
Medicare is a great program
but it needs substantial modification to truly benefit all those it is intended
to serve: the robust, the frail and the demented, and the dying. Just as we don’t
expect one antibiotic to treat all infections or a single chemotherapeutic
agent to treat all types of cancer, we cannot expect one benefit package to
make sense for all older patients. Offering three distinct packages, an intensive
package, a comprehensive package, and a palliative package, as I argued in my book The Denial of Aging, would go a long way
to making Medicare work for everyone.
No comments:
Post a Comment